Amphivena Therapeutics
Amphivena Therapeutics mission is to eradicate blood cancers with a breakthrough therapy that harnesses the patient's own immune system to destroy tumor cells and their precursors. The company is headquartered in San Francisco, California & was founded in 2017.
Last updated on
About Amphivena Therapeutics
Founded
2012Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$103MCategory
Industry
BiotechnologyLocation
City
South San FranciscoState
CaliforniaCountry
United StatesAmphivena Therapeutics
Find your buyer within Amphivena Therapeutics